AstraZeneca (AZN)

Sell: 12,670.00p

Buy: 12,674.00p

Change: -18.00p | -0.14%

Last updated 17:48 24/07/26. Prices delayed by at least 15 minutes. Change is calculated based on previous close price.

Technical analysis

The information in this section is provided by Noesis Tech Analysis not Barclays.

This share factsheet isn’t an investment recommendation. We don’t offer personal advice so if you’re unsure, please seek independent advice. Remember, the value of investments can fall as well as rise and you may get back less than you invest.

Trend

The trend arrows show short, mid and long term signal.

  • Short term:

    Bearish

  • Medium term:

    Strong Bearish

  • Long term:

    Bullish

Short term comment

From a technical point of view, the scenario is bearish under heavy pressure near 1696.125, increasing the risk of overbought and pullbacks. It would have to reclaim 1696.125 to shift to a more neutral scenario.

Long term comment

Although on the 12th of may marked highs at levels at 1925.500, higher levels than the previous reference highs in august 2025 at 1642.732, the current downtrend has lost positions, retreating by -17.6% and falling again below both levels, with lows, at the moment, in quotas of 1587.000.

Technical outlook

Bullish in the long term, although it must still break above the resistance at 21.07 to slightly improve in the short term.

Technical Comment: Outperform

Oscillators

Moving average

View technical details

Pivot points

Pivot points
Support 3 Support 2 Support 1 Resistance 1 Resistance 2 Resistance 3
1590.8330 1617.3330 1633.6670 1660.1670 1670.3330 1696.8330

Alerts

Alerts
Priority Date Warning
Medium priority 27/07/26 Being near (above) the short-term moving average, the price may react temporarily to the upside. However, a break below would turn the signal bearish.
Medium priority 27/07/26 Being near (below) the short-term moving average, the price may lead to a decline, although if it breaks above the level the signal would be reversed to bullish.
Medium priority 27/07/26 Being near (below) the short-term moving average, the price may react at least temporarily to the downside, but if it breaks above the level the signal would be reversed to bullish.
Medium priority 27/07/26 Fast stochastic gives moderate strength signals that may lead to possible short-term rebounds.
High priority 27/07/26 The price is close to a resistance level, so it is recommended to monitor behavior when reaching it.
Medium priority 24/07/26 Being near (above) the short-term moving average, the price may react temporarily to the upside. However, a break below would turn the signal bearish.
Medium priority 24/07/26 Being near (below) the short-term moving average, the price may lead to a decline, although if it breaks above the level the signal would be reversed to bullish.
Medium priority 24/07/26 Being near (below) the short-term moving average, the price may react at least temporarily to the downside, but if it breaks above the level the signal would be reversed to bullish.
Medium priority 24/07/26 Fast stochastic gives moderate strength signals that may lead to possible short-term rebounds.
High priority 24/07/26 The price is close to a resistance level, so it is recommended to monitor behavior when reaching it.
Medium priority 23/07/26 Being near (above) the short-term moving average, the price may react temporarily to the upside. However, a break below would turn the signal bearish.

Thinking about investing?

In order to invest, you’ll first need to be a Smart Investor customer. Compare our accounts and choose the right one for you.

Compare accounts

The information contained on this website and in the tools, data, prices, news, charts, fundamentals and other content made available through it is provided by Communify Europe Limited, unless expressly stated otherwise.

The information is provided for informational purposes only. It does not constitute investment advice, a personal recommendation, investment research, a research recommendation, an invitation or inducement to engage in investment activity, or a recommendation to buy, sell or hold any share, company, fund, investment vehicle or other financial instrument. Communify Europe Limited does not assess the suitability or appropriateness of any investment for any user.

The information is based on sources that Communify Europe Limited considers reliable. However, Communify Europe Limited does not guarantee that the information is accurate, complete, current, uninterrupted, secure or error-free. Prices, quotes and trades may be delayed by at least fifteen minutes unless expressly stated to be provided in real time.

Past performance is not an indicator of future performance. Communify Europe Limited does not guarantee the return of any investment or the performance of any security, company, investment vehicle, index, underlying asset or market. The value of investments may rise or fall, and investors may lose all or part of the amount invested.

To the extent permitted by applicable law, Communify Europe Limited will not be liable for any loss or damage arising from use of the information contained on this website. Nothing in this notice excludes or limits liability for fraud, death or personal injury caused by negligence, breach of the duty to provide services with reasonable care and skill, or any other liability that cannot be excluded or limited under applicable law. Terms and conditions apply.

Copyright © 2026 Refinitiv, an LSEG business. All rights reserved.